首页> 外文期刊>American Journal of Translational Research >Novel methylation-driven genes identified as prognostic indicators for lung squamous cell carcinoma
【24h】

Novel methylation-driven genes identified as prognostic indicators for lung squamous cell carcinoma

机译:新型甲基化驱动基因被鉴定为肺鳞状细胞癌的预后指标

获取原文
           

摘要

Lung cancer remains the leading cause of cancer death. DNA methylation plays an essential role in carcinogenesis through regulating gene expression and gene alternative splicing. However, the role of methylation in the tumorigenesis of lung squamous cell carcinoma (SCC) and its association with prognosis remains unclear. Here, we used an integrative approach to evaluate the prognostic value of epigenetic processes in lung SCC by examining the data provided by The Cancer Genome Atlas (TCGA). We found that the mean methylation level was significantly decreased in lung SCC. We also identified methylation-driven genes which were associated with cancer-related pathways. The multivariate Cox regression analysis showed four methylation-driven genes, GCSAM, GPR75, NHLRC1, and TRIM58, could be served as prognostic indicators for lung SCC. Validation on two external GEO datasets showed consistent methylation alterations of the four genes. These findings may have important implications in the understanding of the potential therapeutic method for lung SCC.
机译:肺癌仍然是癌症死亡的主要原因。 DNA甲基化通过调节基因表达和基因替代剪接在癌变过程中起重要作用。然而,甲基化在肺鳞状细胞癌(SCC)的肿瘤发生中的作用及其与预后的关系仍不清楚。在这里,我们通过检查癌症基因组图谱(TCGA)提供的数据,采用综合方法评估肺SCC表观遗传过程的预后价值。我们发现,肺SCC中的平均甲基化水平显着降低。我们还确定了与癌症相关途径相关的甲基化驱动基因。多元Cox回归分析显示,四个甲基化驱动基因GCSAM,GPR75,NHLRC1和TRIM58可作为肺鳞癌的预后指标。对两个外部GEO数据集的验证显示了四个基因的一致甲基化变化。这些发现可能对理解肺SCC的潜在治疗方法具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号